Factors Influencing Generic Drug Substitution in Switzerland
Author Information
Author(s): Anne Decollogny, Yves Eggli, Patricia Halfon, Thomas M Lufkin
Primary Institution: Centre Hospitalier Universitaire Vaudois and University of Lausanne
Hypothesis
What factors influence the substitution of generic drugs for original formulations in Switzerland?
Conclusion
Patient health status and economic incentives play a role in the reluctance to substitute original formulations with generics, but prescribing behaviors are the main determinant of generic substitution.
Supporting Evidence
- The overall generics' substitution rate was 31%, varying significantly across cantons.
- Poor health status was linked to lower generic use.
- Higher out-of-pocket costs and greater price differences increased generic use.
- Hospital physicians had a 13% lower substitution rate compared to other prescribers.
- Adopting the highest substitution practices could increase rates in other cantons.
Takeaway
This study found that older patients and those with complex treatments are less likely to use generic drugs, while higher out-of-pocket costs encourage their use.
Methodology
The study analyzed reimbursement claims data from a Swiss health insurer using logistic regression to model the use of generics based on patient and market characteristics.
Potential Biases
Potential biases may arise from the non-reimbursement of dispensed drugs for patients who did not seek reimbursement.
Limitations
The study's population was limited to a single health insurer, which may not represent the entire Swiss population.
Participant Demographics
The study included insured individuals from three linguistic regions of Switzerland, with a slightly older demographic compared to the general population.
Statistical Information
Statistical Significance
p<0.05
Digital Object Identifier (DOI)
Want to read the original?
Access the complete publication on the publisher's website